Skip to main content
[Preprint]. 2024 Sep 10:2024.02.14.24302818. [Version 2] doi: 10.1101/2024.02.14.24302818

Table 1.

Staging anchors for application of the NSD-ISS

Biologic anchors Anchors of clinical signs or symptoms (stages 2A and 2B) and functional impairment (stages 3–6)1,2
Stage S D a G Domain Anchor(s)
Stage 0 - - SNCA b
Stage 1A + - ± (1) Cognitive
(2) Motor
(3) Other non-motor
(1) MDS-UPDRS item 1.1=0; and
(2a) Does not have subthreshold parkinsonism c; and (2b) is not on PD medicationd; and
(3a) Does not have RBD; and (3b) is not hyposmic d
Stage IB + + ±
Stage 2A + - ± (1) Cognitive
(2) Motor
(3) Other non-motor
(1) Item 1.1 = 1 AND MoCA ≥ 25; or
(2a) Has subthreshold parkinsonism c; or (2b) is on PD medicationd; or
(3a) Has RBD; or (3b) is hyposmice
Stage 2B + + ±
Stage 3 + + ± (1) Cognitive
(2) Motor
(1a) Item 1.1 = 1 AND MoCA ≤ 24; or (1b) Item 1.1 = 2 AND MoCA ≥ 25; or
(2) MDS-UPDRS-II = 3–13 AND either subthreshold parkinsonism c or PD medicationd
Stage 4 + + ± (1) Cognitive
(2) Motor
(3) Other non-motor
(1a) Item 1.1 = 2 and MoCA ≤ 24; or (1b) item 1.1 = 3 AND MoCA ≥ 25; or
(2) MDS-UPDRS-II = 14–26; or
(3) MDS-UPDRS-I (excluding item 1.1) = 13–24f
Stage 5 + + ± (1) Cognitive
(2) Motor
(3) Other non-motor
(1a) Item 1.1 = 3 AND MoCA ≤ 24; or (1b) item 1.1 = 4 AND MoCA ≥ 25; or
(2) MDS-UPDRS-II = 27–39; or
(3) MDS-UPDRS-I (excluding item 1.1) = 25–36
Stage 6 + + ± (1) Cognitive
(2) Motor
(3) Other non-motor
(1) Item 1.1 = 4 AND MoCA ≤ 24; or
(2) MDS-UPDRS-II ≥ 40; or
(3) MDS-UPDRS-I (excluding item 1.1) ≥ 37